Arora, S., Balasubramaniam, S., Zhang, H., Berman, T., Narayan, P., Suzman, D., . . . Beaver, J. A. (2020). FDA Approval Summary: Olaparib Monotherapy or in Combination with Bevacizumab for the Maintenance Treatment of Patients with Advanced Ovarian Cancer. Oncologist.
Citação norma ChicagoArora, Shaily, et al. "FDA Approval Summary: Olaparib Monotherapy or in Combination With Bevacizumab for the Maintenance Treatment of Patients With Advanced Ovarian Cancer." Oncologist 2020.
Citação norma MLAArora, Shaily, et al. "FDA Approval Summary: Olaparib Monotherapy or in Combination With Bevacizumab for the Maintenance Treatment of Patients With Advanced Ovarian Cancer." Oncologist 2020.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.